Risk of Atrial Fibrillation and Stroke among Taiwan Osteoporosis Population: Alendronate vs. Calcitonin/Raloxifene Users

被引：0
|
作者：
Lin, Tzu-Chieh [1 ]
Yang, Yea-Huei Kao [1 ,2 ]
Yang, Chyun-Yu [3 ]
机构：
[1] Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Dept Orthoped, Tainan 70101, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
690
引用
收藏
页码：S299 / S300
页数：2
相关论文
共 50 条
  • [31] Cost-Effectiveness of Direct Oral Anticoagulant vs Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
    Kim, Jin-Bae
    Kim, Woo-Shik
    Lee, Young-Shin
    CIRCULATION, 2022, 146
  • [32] Reduced Stroke Risk among Patients with Atrial Fibrillation Receiving Chinese Herbal Medicines Treatment: Analysis of Domestic Data in Taiwan
    Zheng, Li-Cheng
    Livneh, Hanoch
    Chen, Wei-Jen
    Lin, Miao-Chiu
    Lu, Ming-Chi
    Yeh, Chia-Chou
    Tsai, Tzung-Yi
    MEDICINA-LITHUANIA, 2020, 56 (06): : 1 - 12
  • [33] The Comparative Mortality of Ischemic Stroke vs. Intracranial Hemorrhage On and Off Warfarin: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    Fang, Margaret C.
    Go, Alan S.
    Chang, Yuchiao
    Borowsky, Leila H.
    Pomernacki, Niela K.
    Udaltsova, Natalia
    Singer, Daniel E.
    STROKE, 2011, 42 (03) : E155 - E155
  • [34] Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
    Steinberg, Benjamin A.
    Hellkamp, Anne S.
    Lokhnygina, Yuliya
    Patel, Manesh R.
    Breithardt, Guenter
    Hankey, Graeme J.
    Becker, Richard C.
    Singer, Daniel E.
    Halperin, Jonathan L.
    Hacke, Werner
    Nessel, Christopher C.
    Berkowitz, Scott D.
    Mahaffey, KennethW.
    Fox, Keith A. A.
    Califf, Robert M.
    Piccini, Jonathan P.
    EUROPEAN HEART JOURNAL, 2015, 36 (05) : 288 - 296
  • [35] Risk of Stroke Among Patients with Gout in Taiwan: A Nationwide Population Study
    Tsai, Ping-Han
    Kuo, Chang-Fu
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [36] Weekend vs. weekday admission and clinical outcomes in heart failure patients with and without atrial fibrillation in Taiwan
    Hu, Wei-Syun
    Lin, Cheng-Li
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (04) : 346 - 352
  • [37] Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation
    Purmah, Yanish
    Proietti, Marco
    Laroche, Cecile
    Mazurek, Michal
    Tahmatzidis, Dimitrios
    Boriani, Giuseppe
    Novo, Salvatore
    Lip, Gregory Y. H.
    EUROPACE, 2018, 20 (02): : 243 - 252
  • [38] Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
    Olesen, Jonas Bjerring
    Fauchier, Laurent
    Lane, Deirdre A.
    Taillandier, Sophie
    Lip, Gregory Y. H.
    CHEST, 2012, 141 (01) : 147 - 153
  • [39] ATRIAL FIBRILLATION/ATRIAL FLUTTER AS UNDERLYING VS. CONTRIBUTING CAUSE OF DEATH IN THE US POPULATION 1999-2020
    Ghajar, Alireza
    Philips, Binu B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 230 - 230
  • [40] The risk vs. benefit calculus of anticoagulation in patients with ibrutinib-related atrial fibrillation
    Patel, Ruchi
    Singh, Arushi
    Meng, Zhiying
    Baldridge, Abigail S.
    Addison, Daniel
    Akhter, Nausheen
    LEUKEMIA & LYMPHOMA, 2024, 65 (02) : 168 - 174
12345